Should Bactrim (Trimethoprim-Sulfamethoxazole) Be Used for Skin Abscesses?
For uncomplicated skin abscesses, incision and drainage is the primary treatment, but adding Bactrim (TMP-SMX) significantly improves cure rates and reduces complications, particularly in settings where MRSA is prevalent. 1
Primary Treatment Approach
Incision and drainage (I&D) is mandatory and the cornerstone of abscess management 1. However, the evidence now clearly demonstrates that I&D alone is insufficient for optimal outcomes.
When to Add Bactrim After I&D
Strong Indications for Antibiotic Therapy
You should prescribe Bactrim after I&D when any of the following are present: 1
- Severe or extensive disease (multiple sites of infection)
- Rapid progression with associated cellulitis
- Systemic signs of illness (fever, tachycardia, hypotension)
- Comorbidities: diabetes, HIV/AIDS, immunosuppression
- Extremes of age (very young or elderly)
- Difficult drainage locations: face, hands, genitalia
- Lack of response to I&D alone
- Associated septic phlebitis
Simple Abscesses Without Complications
Even for simple, uncomplicated abscesses after adequate I&D, Bactrim provides measurable clinical benefit 2, 3:
- Higher cure rates: 92.9% with TMP-SMX vs 85.7% with placebo (7.2% absolute improvement) 2
- Fewer subsequent drainage procedures: 3.4% vs 8.6% 2
- Fewer new infections at different sites: 3.1% vs 10.3% 2
- Fewer household member infections: 1.7% vs 4.1% 2
This benefit exists regardless of abscess size or presence of guideline criteria 4, though the treatment effect is greatest with MRSA infection, fever, or history of MRSA 4.
Dosing and Duration
Standard dosing: TMP-SMX 320/1600 mg (double-strength, 2 tablets) twice daily 2
Duration:
- 7-10 days for most cases 1, 2, 3
- 10 days is superior to 3 days for MRSA infections - shorter courses result in higher failure rates (10.1% difference) and more recurrences 5
MRSA Context
In the current era, 45-55% of skin abscesses are caused by community-associated MRSA 2, 3. TMP-SMX has 95-100% in vitro susceptibility against CA-MRSA 1 and is specifically recommended as first-line empiric therapy for purulent skin infections 1.
Alternative Antibiotics
If TMP-SMX cannot be used, alternatives include 1:
- Clindamycin (but check local resistance rates; use only if <10% resistance)
- Doxycycline or minocycline (avoid in children <8 years)
- Linezolid (effective but expensive, no superiority over cheaper options)
For children: Clindamycin is preferred if local resistance is low 1
Important Caveats
Do NOT use TMP-SMX for:
- Nonpurulent cellulitis without abscess (use beta-lactam for streptococcal coverage) 1
- Pregnant women in third trimester 1
- Infants <2 months of age 6
Monitor for:
- Hyperkalemia (especially in elderly, renal insufficiency, or with ACE inhibitors/ARBs) 6
- Gastrointestinal side effects (mild, more common than placebo) 2
- Rare but serious: Stevens-Johnson syndrome, blood dyscrasias 6
TMP-SMX does NOT adequately cover beta-hemolytic streptococci 1. If purulent cellulitis exists (cellulitis with purulent drainage but no drainable abscess), TMP-SMX alone is appropriate 1. If nonpurulent cellulitis is present, add a beta-lactam like amoxicillin 1.
Common Pitfall
The most frequent error in practice is using antibiotics for simple abscesses without performing adequate I&D 7. The term "cellulitis" should not be applied to inflammation surrounding an abscess - this is simply "abscess with surrounding inflammation," and the treatment is drainage, not antibiotics alone 7.